| Polycystic kidney disease without an apparent family history IA Iliuta, V Kalatharan, K Wang, E Cornec-Le Gall, J Conklin, M Pourafkari, ... Journal of the American Society of Nephrology 28 (9), 2768-2776, 2017 | 101 | 2017 |
| Data capture and sharing in the COVID-19 pandemic: a cause for concern L Dron, V Kalatharan, A Gupta, J Haggstrom, N Zariffa, AD Morris, P Arora, ... The Lancet Digital Health 4 (10), e748-e756, 2022 | 49 | 2022 |
| Opportunities and challenges for genetic studies of end-stage renal disease in Canada V Kalatharan, M Lemaire, MB Lanktree Canadian Journal of Kidney Health and Disease 5, 2054358118789368, 2018 | 13 | 2018 |
| Positive predictive values of international classification of diseases, 10th revision coding algorithms to identify patients with autosomal dominant polycystic kidney disease V Kalatharan, Y Pei, KK Clemens, RK McTavish, SN Dixon, M Rochon, ... Canadian Journal of Kidney Health and Disease 3, 2054358116679130, 2016 | 10 | 2016 |
| Nonconventional diabetes-related care strategies for patients with chronic kidney disease: A scoping review of the literature KK Clemens, V Kalatharan, BL Ryan, S Reichert Journal of Comorbidity 9, 2235042X19831918, 2019 | 6 | 2019 |
| Diagnostic accuracy of administrative codes for autosomal dominant polycystic kidney disease in clinic patients with cystic kidney disease V Kalatharan, E McArthur, DM Nash, B Welk, S Sarma, AX Garg, Y Pei Clinical kidney journal 14 (2), 612-616, 2021 | 5 | 2021 |
| Risk of hospital encounters with kidney stones in autosomal dominant polycystic kidney disease: a cohort study V Kalatharan, B Welk, DM Nash, SN Dixon, J Slater, Y Pei, S Sarma, ... Canadian journal of kidney health and disease 8, 20543581211000227, 2021 | 4 | 2021 |
| Stone prevalence in autosomal dominant polycystic kidney disease: a systematic review and meta-analysis V Kalatharan, G Grewal, DM Nash, B Welk, S Sarma, Y Pei, AX Garg Canadian Journal of Kidney Health and Disease 7, 2054358120934628, 2020 | 3 | 2020 |
| Efficacy and safety of surgical kidney stone interventions in autosomal dominant polycystic kidney disease: a systematic review V Kalatharan, R Jandoc, G Grewal, DM Nash, B Welk, S Sarma, Y Pei, ... Canadian Journal of Kidney Health and Disease 7, 2054358120940433, 2020 | 2 | 2020 |
| Assessing the performance of group‐based trajectory modeling method to discover different patterns of medication adherence A Diop, A Gupta, S Mueller, L Dron, O Harari, H Berringer, V Kalatharan, ... Pharmaceutical Statistics, 2024 | | 2024 |
| Incidence and Prevalence of Cardiovascular and Metabolic Diseases Following Gout Diagnosis in the United Kingdom Using the THIN Database M Garshick, H Patel, A Kumar, B LaMoreaux, L Padnick-Silver, L Dron, ... ARTHRITIS & RHEUMATOLOGY 75, 465-466, 2023 | | 2023 |
| Benefit-Risk Assessment of Medical Products Using Bayesian Multi-Criteria Augmented Decision Analysis (MCADA) for Clinical Development HJ Berringer, O Harari, V Kalatharan, A Diop, EJH Mills, JJH Park medRxiv, 2023.08. 31.23294918, 2023 | | 2023 |
| Complications in Patients With Autosomal Dominant Polycystic Kidney Disease Undergoing Ureteroscopy: A Cohort Study V Kalatharan, B Welk, DM Nash, E McArthur, J Slater, S Sarma, Y Pei, ... Canadian Journal of Kidney Health and Disease 7, 2054358120972830, 2020 | | 2020 |
| Epidemiology of upper urinary tract stones and stone management in autosomal dominant polycystic kidney disease V Kalatharan The University of Western Ontario (Canada), 2020 | | 2020 |
sisira sarmaUniversity of Western Ontario在 uwo.ca 的电子邮件经过验证
